Asmus MJ. Sherman J. Hendeles L.  Bronchoconstrictor additives in bronchodilator solutions. Journal of Allergy & Clinical Immunology. 104(2 Pt 2):S53-60, 1999.

Bick RL. Frenkel EP.  Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy. Clinical & Applied Thrombosis-Hemostasis. 5 Suppl 1:S7-15, 1999.

Chang TW.  The pharmacological basis of anti-IgE therapy. Nature Biotechnology. 18(2):157-62, 2000.

Cobert B, Silvey J.  The Internet and drug safety: what are the implications for pharmacovigilance? Drug Safety. 20(2):95-107, 1999.

Cocks TM. Moffatt JD.  Protease-activated receptors: sentries for inflammation? Trends in Pharmacological Sciences. 21(3):103-8, 2000.

deShazo RD. Kemp SF.  Allergic reactions to drugs and biologic agents. JAMA. 278(22):1895-906, 1997.

Doutre M.  Physiopathology of urticaria [editorial]. European Journal of Dermatology. 9(8):601-5, 1999.

Eggleston ST. Lush LW.  Understanding allergic reactions to local anesthetics. Annals of Pharmacotherapy. 30(7-8):851-7, 1996.

Gall H. Kaufmann R. Kalveram CM.  Adverse reactions to local anesthetics: analysis of 197 cases. Journal of Allergy & Clinical Immunology. 97(4):933-7, 1996.

Giembycz MA.  Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs. 59(2):193-212, 2000.

Heard K. O'Malley GF. Dart RC.  Antivenom therapy in the Americas. Drugs. 58(1):5-15, 1999.

Huang SM. Lesko LJ. Williams RL.  Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues. Journal of Clinical Pharmacology. 39(10):1006-14, 1999.

Laxenaire MC.  Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey Annales Francaises d Anesthesie et de Reanimation. 18(7):796-809, 1999.

Levy JH.  Hemostatic agents and their safety. Journal of Cardiothoracic & Vascular Anesthesia. 13(4 Suppl 1):6-11; discussion 36-7, 1999.

Macdougall IC.  Strategies for iron supplementation: oral versus intravenous. Kidney International - Supplement. 69:S61-6, 1999.

Marsh JE. Pratt JR. Sacks SH.  Targeting the complement system. Current Opinion in Nephrology & Hypertension. 8(5):557-62, 1999.

Mekori YA. Metcalfe DD.  Mast cells in innate immunity. Immunological Reviews. 173:131-40, 2000.

Metcalfe DD.  Differential diagnosis of the patient with unexplained flushing/anaphylaxis. Allergy & Asthma Proceedings. 21(1):21-4, 2000.

Naguib M. Magboul MM. Samarkandi AH. Attia M.  Adverse effects and drug interactions associated with local and regional anaesthesia. Drug Safety. 18(4):221-50, 1998.

Noga O. Brunnee T. Schaper C. Kunkel G.  Heparin, derived from the mast cells of human lungs is responsible for the generation of kinins in allergic reactions due to the activation of the contact system. International Archives of Allergy & Immunology. 120(4):310-6, 1999.

Nydegger UE. Sturzenegger M.  Adverse effects of intravenous immunoglobulin therapy. Drug Safety. 21(3):171-85, 1999.

Opal SM. DePalo VA.  Anti-inflammatory cytokines Chest. 117(4):1162-72, 2000.

Pellas TC. Wennogle LP.  C5a receptor antagonists. Current Pharmaceutical Design. 5(10):737-55, 1999.

Shadick NA. Liang MH. Partridge AJ. Bingham C. Wright E. Fossel AH. Sheffer AL.  The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. Journal of Allergy & Clinical Immunology. 104(1):123-7, 1999.

Torres MJ. Mayorga C. Pamies R. Rodriquez JL. Juarez C. Romano A. Blanca M.  Immunologic response to different determinants of benzylpenicillin, amoxicillin, and ampicillin. Comparison between urticaria and anaphylactic shock. Allergy. 54(9):936-43, 1999.

van der Klauw MM. Wilson JH. Stricker BH.  Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature. Clinical & Experimental Allergy. 26(12):1355-63, 1996.

Veien M. Szlam F. Holden JT. Yamaguchi K. Denson DD. Levy JH.  Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology. 92(4):1074-81, 2000.

Weekes LM. Day RO.  The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective. Drug Safety. 18(3):153-9, 1998.

Wuthrich B.  Food-induced cutaneous adverse reactions. Allergy. 53(46 Suppl):131-5, 1999.

Yocum MW. Butterfield JH. Klein JS. Volcheck GW. Schroeder DR. Silverstein MD.  Epidemiology of anaphylaxis in Olmsted County: A population-based study. Journal of Allergy & Clinical Immunology. 104(2 Pt 1):452-6, 1999.